<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82610</article-id><article-id pub-id-type="doi">10.7554/eLife.82610</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Transmission Histories</subject></subj-group></article-categories><title-group><article-title>Traversing missing links in the spread of HIV</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-291305"><name><surname>Brintnell</surname><given-names>Erin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5042-7799</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Erin Brintnell</bold> is in the Department of Pathology and Laboratory Medicine, Western University, London, Canada </p></bio></contrib><contrib contrib-type="author" corresp="yes" id="author-149994"><name><surname>Poon</surname><given-names>Art</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3779-154X</contrib-id><email>apoon42@uwo.ca</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Art Poon</bold> in the Department of Pathology and Laboratory Medicine, the Department of Microbiology and Immunology, and the Department of Computer Science, Western University, London, Canada</p></bio></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02grkyz14</institution-id><institution>Department of Pathology and Laboratory Medicine, Western University</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>Canada</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02grkyz14</institution-id><institution>Department of Computer Science, Western University</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>Canada</country></aff></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>30</day><month>09</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e82610</elocation-id><permissions><copyright-statement>© 2022, Brintnell and Poon</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Brintnell and Poon</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82610-v1.pdf"/><related-article related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.7554/eLife.76487" id="ra1"/><abstract><p>Combining clinical and genetic data can improve the effectiveness of virus tracking with the aim of reducing the number of HIV cases by 2030.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>HIV-1</kwd><kwd>phylogenetics</kwd><kwd>transmission chains</kwd><kwd>molecular epidemiology</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Combining clinical and genetic data can improve the effectiveness of virus tracking with the aim of reducing the number of HIV cases by 2030.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Blenkinsop A, Monod M, van Sighem A, Pantazis N, Bezemer D, Op de Coul E, van de Laar T, Fraser C, Prins M, Reiss P, de Bree GJ, Ratmann O. 2022. Estimating the potential to prevent locally acquired HIV infections in a UNAIDS fast-track City, Amsterdam. <italic>eLife</italic> <bold>11</bold>:e76487. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.76487">10.7554/eLife.76487</ext-link>.</p></boxed-text><p>The human immunodeficiency virus type 1 (HIV-1), which can lead to acquired immune deficiency syndrome (AIDS), remains a leading cause of death and a health threat worldwide, with over 38.4 million people currently living with the virus. Global health sector strategies strive to end HIV-1 epidemics by 2030 (<xref ref-type="bibr" rid="bib7">Duncombe et al., 2019</xref>). This requires significant investment in resources to treat and prevent the disease, such as reducing the number of people who do not know they are carrying the virus and improving the availability and affordability of effective treatments.</p><p>In cities that have scaled up HIV-1 treatment and prevention, it will be crucial to establish whether new HIV-1 infections are due to ongoing local transmission or to infections acquired abroad. This means reconstructing the spread of HIV-1 between individuals through contact tracing: interviewing people recently diagnosed with HIV, and locating and notifying their intimate partners. However, contact tracing is both time-consuming and intrusive (<xref ref-type="bibr" rid="bib8">El-Sadr et al., 2022</xref>).</p><p>A cost-effective alternative to contact tracing is to compare the genomic sequences of HIV-1 samples from different patients, which are often collected to screen for mutations that confer drug resistance. Infections that are genetically similar are more likely to be related through recent transmissions. This is especially true for HIV-1, a rapidly evolving virus that becomes genetically unique within months of an infection (<xref ref-type="bibr" rid="bib11">Williamson, 2003</xref>).</p><p>These genetic sequences can be used to build a tree that represents the shared evolutionary history of the infections and approximates the history of recent transmissions (<xref ref-type="bibr" rid="bib5">De Maio et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Romero-Severson et al., 2014</xref>). Furthermore, the spread of infections from one place to another can be extrapolated by reconstructing locations of ‘ancestral’ infections at deeper nodes of the tree from the known locations at the tips (<xref ref-type="bibr" rid="bib9">Faria et al., 2011</xref>). The accuracy of these estimates, however, is impeded by the unknown number of people with undiagnosed infections, or with diagnosed infections that have not been sequenced (<xref ref-type="bibr" rid="bib6">Didelot et al., 2017</xref>). In addition, reconstructing transmission patterns from HIV-1 sequences comes with its own ethical challenges because HIV-1 transmission is criminalized in many countries (<xref ref-type="bibr" rid="bib4">Dawson et al., 2020</xref>).</p><p>Now, in eLife, Oliver Ratmann at the HIV Transmission Elimination Amsterdam Consortium and colleagues – including Alexandra Blenkinsop as first author – report an innovative approach to overcome the disadvantages of sequence analysis (<xref ref-type="bibr" rid="bib1">Blenkinsop et al., 2022</xref>). Blenkinsop et al. combined different data sources to reconstruct the transmission histories of HIV-1 in Amsterdam, which has the highest concentration of HIV-1 cases in the Netherlands. Amsterdam is also part of the Fast-Track city network, which provides funds to expand effective HIV prevention, testing and treatment services.</p><p>Blenkinsop et al. extended the standard approach of reconstructing transmission histories from HIV-1 sequences by incorporating additional information from clinical biomarkers (biological indicators of disease progression or response to treatment) and other patient data (<xref ref-type="fig" rid="fig1">Figure 1</xref>). A statistical model was fitted to two biomarkers: the number of HIV-1 particles circulating in the blood (the viral load) and the number of white blood cells targeted by HIV-1. Based on how these biomarkers changed over time, it was possible to estimate the length of time between a person’s HIV-1 infection and diagnosis. These estimates were then used to infer how many cases were transmitted from people with unsequenced infections, adjusting for factors like route of transmission (e.g., injection drug use), age group, and place of birth.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Estimating the number of unsampled HIV-1 infections.</title><p>The top panel illustrates how a chain of HIV-1 infections may be partially sampled over time. The top dashed line shows an infection (represented by the virus particle symbol) that is transmitted (red arrow) before it is sequenced (DNA symbol), with the time between the infection occurring and sequencing taking place indicated by the two-headed arrow. The dashed line in the centre shows an infection resulting from transmission from the first infection, which is transmitted (red arrow) but never sequenced. The dashed line on the bottom represents a third infection resulting from the second infection, that is sequenced (DNA symbol) more quickly than the original infection. The bottom panel depicts two phylogenetic trees. The first tree (green) is inferred from the available sequences (in this case, the two infections sequenced in the top panel). By fitting a statistical model to HIV-1 cases with estimated dates of infection and clinical data, the number of unsampled infections (‘missing links’) in the new tree (red) can be extrapolated for different populations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82610-fig1-v1.tif"/></fig><p>Despite extensive measures to curb the transmission of HIV in Amsterdam, results from Blenkinsop et al. suggest that many HIV-1 infections have remained undiagnosed for a long time, especially among heterosexual residents and recent arrivals from sub-Saharan Africa. Further, they provide evidence of ongoing HIV-1 transmission within the city over the duration of the five-year study. These results suggest that, while Amsterdam has made significant progress in reducing the spread of HIV-1, closing the final gap to end the local epidemic by 2030 remains a challenge.</p><p>The study also highlights the importance of linking HIV-1 sequences to both clinical and demographic information to determine which groups have been neglected by the generalized scale-up of public health testing and treatment. This may also be a critical step for other cities in the FastTrack initiative. Furthermore, the work of Blenkinsop et al. mirrors ongoing challenges in tracking and controlling other infectious diseases like COVID-19, which is characterised by an abundance of viral genome sequences but a lack of linked contextual information, including clinical outcomes, travel histories and sampling strategies (<xref ref-type="bibr" rid="bib3">Chiara et al., 2021</xref>; <xref ref-type="bibr" rid="bib2">Chen et al., 2022</xref>).</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blenkinsop</surname><given-names>A</given-names></name><name><surname>Monod</surname><given-names>M</given-names></name><name><surname>van Sighem</surname><given-names>A</given-names></name><name><surname>Pantazis</surname><given-names>N</given-names></name><name><surname>Bezemer</surname><given-names>D</given-names></name><name><surname>Op de Coul</surname><given-names>E</given-names></name><name><surname>van de Laar</surname><given-names>T</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Prins</surname><given-names>M</given-names></name><name><surname>Reiss</surname><given-names>P</given-names></name><name><surname>de Bree</surname><given-names>GJ</given-names></name><name><surname>Ratmann</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Estimating the potential to prevent locally acquired HIV infections in a UNAIDS fast-track City, Amsterdam</article-title><source>eLife</source><volume>11</volume><elocation-id>e76487</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.76487</pub-id><pub-id pub-id-type="pmid">35920649</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Azman</surname><given-names>AS</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Ge</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Leung</surname><given-names>DT</given-names></name><name><surname>Domman</surname><given-names>DB</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Global landscape of SARS-CoV-2 genomic surveillance and data sharing</article-title><source>Nature Genetics</source><volume>54</volume><fpage>499</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01033-y</pub-id><pub-id pub-id-type="pmid">35347305</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiara</surname><given-names>M</given-names></name><name><surname>D’Erchia</surname><given-names>AM</given-names></name><name><surname>Gissi</surname><given-names>C</given-names></name><name><surname>Manzari</surname><given-names>C</given-names></name><name><surname>Parisi</surname><given-names>A</given-names></name><name><surname>Resta</surname><given-names>N</given-names></name><name><surname>Zambelli</surname><given-names>F</given-names></name><name><surname>Picardi</surname><given-names>E</given-names></name><name><surname>Pavesi</surname><given-names>G</given-names></name><name><surname>Horner</surname><given-names>DS</given-names></name><name><surname>Pesole</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities</article-title><source>Briefings in Bioinformatics</source><volume>22</volume><fpage>616</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1093/bib/bbaa297</pub-id><pub-id pub-id-type="pmid">33279989</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>L</given-names></name><name><surname>Benbow</surname><given-names>N</given-names></name><name><surname>Fletcher</surname><given-names>FE</given-names></name><name><surname>Kassaye</surname><given-names>S</given-names></name><name><surname>Killelea</surname><given-names>A</given-names></name><name><surname>Latham</surname><given-names>SR</given-names></name><name><surname>Lee</surname><given-names>LM</given-names></name><name><surname>Leitner</surname><given-names>T</given-names></name><name><surname>Little</surname><given-names>SJ</given-names></name><name><surname>Mehta</surname><given-names>SR</given-names></name><name><surname>Martinez</surname><given-names>O</given-names></name><name><surname>Minalga</surname><given-names>B</given-names></name><name><surname>Poon</surname><given-names>A</given-names></name><name><surname>Rennie</surname><given-names>S</given-names></name><name><surname>Sugarman</surname><given-names>J</given-names></name><name><surname>Sweeney</surname><given-names>P</given-names></name><name><surname>Torian</surname><given-names>LV</given-names></name><name><surname>Wertheim</surname><given-names>JO</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Addressing ethical challenges in US-based HIV phylogenetic research</article-title><source>The Journal of Infectious Diseases</source><volume>222</volume><fpage>1997</fpage><lpage>2006</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiaa107</pub-id><pub-id pub-id-type="pmid">32525980</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Maio</surname><given-names>N</given-names></name><name><surname>Worby</surname><given-names>CJ</given-names></name><name><surname>Wilson</surname><given-names>DJ</given-names></name><name><surname>Stoesser</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Bayesian reconstruction of transmission within outbreaks using genomic variants</article-title><source>PLOS Computational Biology</source><volume>14</volume><elocation-id>e1006117</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006117</pub-id><pub-id pub-id-type="pmid">29668677</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didelot</surname><given-names>X</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Gardy</surname><given-names>J</given-names></name><name><surname>Colijn</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genomic infectious disease epidemiology in partially sampled and ongoing outbreaks</article-title><source>Molecular Biology and Evolution</source><volume>34</volume><fpage>997</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1093/molbev/msw275</pub-id><pub-id pub-id-type="pmid">28100788</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncombe</surname><given-names>C</given-names></name><name><surname>Ravishankar</surname><given-names>S</given-names></name><name><surname>Zuniga</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fast-track cities: striving to end urban HIV epidemics by 2030</article-title><source>Current Opinion in HIV and AIDS</source><volume>14</volume><fpage>503</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1097/COH.0000000000000583</pub-id><pub-id pub-id-type="pmid">31567436</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sadr</surname><given-names>WM</given-names></name><name><surname>Platt</surname><given-names>J</given-names></name><name><surname>Bernitz</surname><given-names>M</given-names></name><name><surname>Reyes</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Contact tracing: barriers and facilitators</article-title><source>American Journal of Public Health</source><volume>112</volume><fpage>1025</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.2105/AJPH.2022.306842</pub-id><pub-id pub-id-type="pmid">35653650</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>NR</given-names></name><name><surname>Suchard</surname><given-names>MA</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Lemey</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Toward a quantitative understanding of viral phylogeography</article-title><source>Current Opinion in Virology</source><volume>1</volume><fpage>423</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2011.10.003</pub-id><pub-id pub-id-type="pmid">22440846</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero-Severson</surname><given-names>E</given-names></name><name><surname>Skar</surname><given-names>H</given-names></name><name><surname>Bulla</surname><given-names>I</given-names></name><name><surname>Albert</surname><given-names>J</given-names></name><name><surname>Leitner</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Timing and order of transmission events is not directly reflected in a pathogen phylogeny</article-title><source>Molecular Biology and Evolution</source><volume>31</volume><fpage>2472</fpage><lpage>2482</lpage><pub-id pub-id-type="doi">10.1093/molbev/msu179</pub-id><pub-id pub-id-type="pmid">24874208</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression</article-title><source>Molecular Biology and Evolution</source><volume>20</volume><fpage>1318</fpage><lpage>1325</lpage><pub-id pub-id-type="doi">10.1093/molbev/msg144</pub-id><pub-id pub-id-type="pmid">12777505</pub-id></element-citation></ref></ref-list></back></article>